Chemical function based pharmacophore generation of endothelin-A selective receptor antagonists.
Both quantitative and qualitative chemical function based pharmacophore models of endothelin-A (ET(A)) selective receptor antagonists were generated by using the two algorithms HypoGen and HipHop, respectively, which are implemented in the Catalyst molecular modeling software. The input for HypoGen is a training set of 18 ET(A) antagonists exhibiting IC(50) values ranging between 0.19 nM and 67 microM. The best output hypothesis consists of five features: two hydrophobic (HY), one ring aromatic (RA), one hydrogen bond acceptor (HBA), and one negative ionizable (NI) function. The highest scoring Hip Hop model consists of six features: three hydrophobic (HY), one ring aromatic (RA), one hydrogen bond acceptor (HBA), and one negative ionizable (NI). It is the result of an input of three highly active, selective, and structurally diverse ET(A) antagonists. The predictive power of the quantitative model could be approved by using a test set of 30 compounds, whose activity values spread over 6 orders of magnitude. The two pharmacophores were tested according to their ability to extract known endothelin antagonists from the 3D molecular structure database of Derwent's World Drug Index. Thereby the main part of selective ET(A) antagonistic entries was detected by the two hypotheses. Furthermore, the pharmacophores were used to screen the Maybridge database. Six compounds were chosen from the output hit lists for in vitro testing of their ability to displace endothelin-1 from its receptor. Two of these are new potential lead compounds because they are structurally novel and exhibit satisfactory activity in the binding assay.
Funk
Oliver F
OF
Department of Pharmaceutical Chemistry, Institute of Pharmacy, University of Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria. thierry.lanfer@uibk.ac.at
Kettmann
Viktor
V
Drimal
Jan
J
Langer
Thierry
T
D000465:Algorithms; D000818:Animals; D001667:Binding, Competitive; D002522:Chlorocebus aethiops; D016208:Databases, Factual; D065130:Endothelin A Receptor Antagonists; D006571:Heterocyclic Compounds / Q000737:chemistry* / Q000494:pharmacology; D006801:Humans; D008958:Models, Molecular; D015394:Molecular Structure; D011869:Radioligand Assay; D044022:Receptor, Endothelin A / Q000737:chemistry; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D014709:Vero Cells
D065130:Endothelin A Receptor Antagonists; D006571:Heterocyclic Compounds; D044022:Receptor, Endothelin A